FREDERICK, Md., May 25 /PRNewswire-FirstCall/ -- BioElectronics Corporation, , announced today that Eximeq, a provider of Health Care services, penetrated the Mexican Market to introduce ActiPatch, the unique drug free therapy for treatment of swelling, pain, and soft and hard tissues injuries.
"I am excited by the potential to bring the healing benefits of ActiPatch to the medical professionals in Mexico. The proven technology of ActiPatch will improve the lives of people and we are genuinely pleased to be conduit for this product. We are looking forward to an excellent relationship with BioElectronics," said Alberto Barona, President of Eximeq.
"We are encouraged and excited to see the growth in International Distribution that has taken place recently for our company. I know that this relationship with Eximeq will benefit not only both companies but more importantly, bring the healing benefits of ActiPatch to the people of Mexico," said Andrew Whelan, President of BioElectronics Corporation.
About Eximeq:
Founded in 1997 Eximeq has provided the medical professional market in Mexico with the latest technology available. Alberto Barona has over 25 years experience in the medical technology field. To learn more about Eximeq please visit http://www.eximeq.com.
About BioElectronics:
BioElectronics Corporation is the maker of ActiPatch(TM). ActiPatch is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.
For more information visit http://www.bioelectronicscorp.com
Safe Harbor Statement:
This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.
BioElectronics CorporationCONTACT: Andrew J. Whelan, President and CEO of BioElectronicsCorporation, +1-866-757-2284, Fax: 301-874-6935, info@actipatch.net
